Exposure to sorbitol induces resistance to cisplatin in human non-small-cell lung cancer cell lines

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3345-3348

  Bando, Takuma ^a   Fujimura, Masaki ^a   Kasahara, Kazuo ^a   Shibata, Kazuhiko ^a   Shirasaki, Hiroki ^a   Heki, Utako ^a   Iwasa, Kei Ichi ^a   Ueda, Akiko ^a   Tomikawa, Saori ^a   Matsuda, Tamotsu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cisplatin; Intracellular accumulation; K+ ATPase; Lung cancer; Na+; Sorbitol

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; SORBITOL;

ARTICLE; CANCER CELL CULTURE; DRUG ACCUMULATION; DRUG RESISTANCE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; NA(+)-K(+)-EXCHANGING ATPASE; SORBITOL; TUMOR CELLS, CULTURED;

EID: 0030781080     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Loehrer P JA and Einhorr L H: Cisplatin. Anr Intern Med 100: 704-713, 1984.
2. DeVita VT, Hellmarb S and Rodenberg SA: Cancer. Principles and Practice of Oncology, 4th ed., p673-758, J. B. Lippincott Co., Philadelphia, 1993.
3. DeGraff A, Slebos RJC and Rodenhuis S: Resistance to cisplatin and analogues: mechanisms and potential clinical implications. Cancer Chemother Pharmacol 22: 325-332, (1988).
4. Hospers GA.P, Mulder NH and DeVries EG. E: Mechanisms of cellular resistance to cisplatin (review). Med. Oncol. Tumor Pharmacother 5: 145-151 (1988).
5. Kelley SL and Rosencweig M: Resistance to platinum compounds: mechanisms and beyond. Eur. J. Cancer Clin. Oncol 25: 1135-1140 (1989).
6. Andrews PA and Howell SB: Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43, 1990.
7. Andrews PA, Murphy MP and Howell SB: Metallothionein mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother. Pharmacol 241: 1813-1815, 1987.
8. Tew KD, Bomber AM and Hoffmarl SJ: Ethacrynic acid and piriprost as enhancer of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res 48: 3622-3625, 1988.
9. Basu A and Lazo JS: A hypothesis regarding the prospective role of metallothionein against the toxicity of DNA intercalating drugs. Toxicol. Lett 50: 123-125, 1990.
10. Fujiwara Y, Sugimoto Y, Kasahara K, Bungo M, Yamakido M, Tew KD and Saijo N: Determinant of drug response in a cisplatin resistant human lung cancer cell line. Jpn J Cancer Res 81: 527-535, 1990.
11. Nakagawa K, Saijo N, Tsuchida S, Sakai M, Tsunokawa Y, Yokota J, Muramatsu M, Sato K, Terada M and Tew KD: Glutathione-S-transferase π as a determinant of drug resistance in transfectant cell lines. J Biol Chem 265: 4296-4301, 1990.
12. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda Tand Saijo N: Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 51: 3237-3242, 991.
13. Eastman A and Schulte, M. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry 27: 4730-4734, 1988.
14. Timmer-Bosscha Y, Mulder NH and DeVries EGE: Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br J Cancer 66: 227-238, 1992.
15. Gatery DP and Howell SB: Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67: 1171-1176, 1993.
16. Bungo M, Fujiwara Y, Kasahara K, Nakagawa K, Ohe Y, Sasaki Y, Irino S and Saijo N: Decreased accumulation as a mechanisms of resistance to cis-diamminedichloropaltinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res 50: 2549-2553, 1990.
17. Horisberger J-D, Lemas V, Kraehenbuhl J-P and Rossier BC Structure-function relationship of Na, K-ATPase. Annu Rev Physiol 53: 565-584 1991.
18. Behse F, Buchtal F and Carsen FI: Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatr 40: 1072-1082, 1977.
19. Steinmetz PR and Balko C: The sorbitol pathway and the complication of diabetes. N Engl J Med 288: 831-836, 1973.
20. Judzewitsch RG, Jaspan JB, and Polonsku KS: Aldose reductase inhibition improves nerve conduction velosity in diabetic patients. N Engl J Med 308: 119-125, 1983.
21. Ruderman NB and Haudenschild C: Diabetes as an atherogenic factor. Prog Cardiovasc Dis 26: 373-412, 1984.
22. Bando T, Kasahara K, Shibata K, Nakatsumi Y, Fujimura M and Matsuda, T. Role of DT-diaphorase as a determinant of sensitivity to mitomycin analogue in non-small cell lung cancer cell lines. Int J Oncol 5: 814-825, 1994.
23. Bando T, Kasahara K, Shibata K, Numata Y, Heki U, Shirasaki H, Iwasa K, Fujimura M and Matsuda T: Cytotoxicity of a novel indoloquinone EO9 in hypoxic non-small cell lung cancer cell lines. Int J Oncol 7: 789-793, 1995.
24. Bando T, Kasahara K, Shibata K, Numata Y, Heki U, Shirasaki H, Iwasa K, Fujimura M and Matsuda T: Modulation of sensitivity to mitomycin C and its dithiol analogue by tempol in non-small cell lung cancer cell lines under hypoxia. J Cancer Res Clin Oncol 122: 21-26 1996.
25. Losengurt E and Heppel LA: Serum rapidly stimulates ouabain-sensitive Rb influx in quiescent 3T3 cells. Proc Natl Acad Sci USA 72: 4492-4495, 1975.
26. Ohmori T, Nlishio K, Ohta S, Kubota N, Adachi M, Komiya K and Saijo N: Ouabain-resistant non-small-cell lung-cancer cell line shows collateral sensitivity to cis-diamminedichloroplatinum(II) (CDDP). Int J Cancer 57: 111-116, 1994.
27. Ohmori T, Morikage T, Sugimoto Y, Fujiwara Y, Kasahara K, Nishio K, Ohta S, Sasaki Y, Takahashi T and Saijo N: The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP). Jpn J Cancer Res 84: 83-92, 1993.
28. + adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells. Cancer Res 51: 3677-3681, 1991.
29. 2 receptor antagonists in non-small-cell lung cancer cell lines. Br J Cancer 74: 1553-1558, 1996.
30. Brown LB, Jakubowski JA, Leventis LL and Deykin D: Elevated glucose alters eicosanoid release from porcine aortic endothelial cells. J Clin Invest 82: 2136-2141, 1988.
31. + - ATPase activity in rabibit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. J Clin Invest 90: 727-732, 1992.
32. 2 attenuates sensitivity to cis-diamminedichloroplatinum(II) (CDDP) in non-small cell lung cancer cell lines in vitro. Proc Am Assoc Cancer Res 865, 1995.